Satellos to Present Data on SAT-3247 Pilot Study at World Muscle Society Meeting

MT NewswiresOct 1 08:08 ET

Satellos Bioscience Inc. Initiated at Speculative Buy by Canaccord Genuity

Dow JonesSep 23 11:41 ET · Ratings

Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247

BusinesswireSep 18 07:00 ET

Satellos Announces Participation in September 2024 Investor Conferences

BusinesswireSep 5 07:00 ET

Satellos Bioscience Given Go-ahead for Phase 1 Clinical Trial With SAT-3247 in Australia

MT NewswiresAug 19 09:19 ET

Satellos Bioscience Brief: Adds "On Track: to Dose First Participant in Phase 1 Clinical Trial With SAT-3247 in Q3 2024; Cites Cash Balance of $27.7 Million at June 30, 2024

MT NewswiresAug 12 07:20 ET